Compare INVZ & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INVZ | PMN |
|---|---|---|
| Founded | 2016 | 2004 |
| Country | Israel | Canada |
| Employees | 415 | N/A |
| Industry | Auto Parts:O.E.M. | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.1M | 115.5M |
| IPO Year | N/A | 2022 |
| Metric | INVZ | PMN |
|---|---|---|
| Price | $0.68 | $11.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $2.68 | ★ $42.67 |
| AVG Volume (30 Days) | ★ 2.1M | 39.2K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.61 | N/A |
| Revenue Next Year | $53.57 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.58 | $0.29 |
| 52 Week High | $2.54 | $27.40 |
| Indicator | INVZ | PMN |
|---|---|---|
| Relative Strength Index (RSI) | 49.30 | 37.47 |
| Support Level | $0.61 | $10.55 |
| Resistance Level | $0.72 | $13.80 |
| Average True Range (ATR) | 0.06 | 0.84 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 51.44 | 16.72 |
Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.